Tag: intravenous (iv)

JAMA Publishes Trial Results Delayed 5 Years. Here’s Why

A treatment for shortening the painful episodes of sickle cell disease (SCD) is not effective, results published in JAMA indicate. But the effort it took...

An Effective Alternative to Opioids for Acute Pain?

Intranasal (IN) ketamine may be a safe and effective alternative to intravenous opioids for acute pain in adult patients, new research suggests. In a systematic...

FDA OKs First ‘Targeted Treatment’ for Rare DMD Mutation

The US Food and Drug Administration (FDA) has approved the antisense oligonucleotide casimersen (Amondys 45, Sarepta Therapeutics) injection for the treatment of patients with Duchenne...

Repeated Ketamine Infusions Linked to Rapid Relief of PTSD

Repeated intravenous infusions of ketamine provide rapid relief for patients with posttraumatic stress disorder (PTSD), new research suggests. In what investigators are calling the first...

New ‘Wake-up’ Stroke Analysis Strengthens Case for Thrombolysis

Evidence supporting the use of thrombolysis for selected stroke patients with unknown time of onset has been strengthened with data from a new individual patient...

Some Data May Be Worse Than No Data in the COVID Era

What your doctor is reading on Medscape.com: MAY 14, 2020 — I will critique a research letter on anticoagulation in patients with COVID-19 recently published...

Neoadjuvant Nivolumab ‘Promising’ in Merkel Cell Carcinoma

Neoadjuvant nivolumab (Opdivo, Bristol-Myers Squibb) could improve outcomes for patients with high-risk resectable Merkel cell carcinoma (MCC), say researchers reporting the first trial in this...

FDA Authorizes Emergency Use of Remdesivir for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) today issued an emergency...

Early Sepsis Care Bundle Does Not Reduce Mortality

NEW YORK (Reuters Health) – A care bundle for early sepsis management might not reduce mortality or organ dysfunction in patients with community-onset or hospital-onset...

EMA Restricts Fosfomycin Use Following Evidence Review

The European Medicines Agency (EMA) has recommended a number of changes regarding the use of fosfomycin-based antibiotics, including recommending the suspension of use of pediatric...